Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 140 | 1,327 | 854 | 1,076 | 760 |
| Marketable Securities | 62 | 64 | 65 | 65 | 65 |
| Receivables | 196 | 763 | N/A | N/A | N/A |
| Inventories | N/A | N/A | 12 | 12 | 12 |
| Other current assets | 0 | 0 | 1,934 | 1,422 | 537 |
| TOTAL | $649 | $2,501 | $3,312 | $2,770 | $1,470 |
| Non-Current Assets | |||||
| PPE Net | 12,823 | 12,835 | 12,854 | 8,215 | 8,169 |
| Investments And Advances | 3,636 | 3,003 | 3,870 | 3,963 | 3,885 |
| Other Non-Current Assets | 2,625 | 2,722 | 1,178 | 1,293 | 1,353 |
| TOTAL | $19,084 | $18,561 | $17,902 | $13,471 | $13,406 |
| Total Assets | $19,733 | $21,062 | $21,214 | $16,241 | $14,876 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 81 | N/A |
| Accounts payable and accrued liabilities | 0 | 106 | 0 | 729 | 819 |
| Accrued Expenses | 4,154 | 4,162 | 3,991 | 4,291 | 3,827 |
| Other current liabilities | 13 | 13 | 1,318 | N/A | 81 |
| TOTAL | $5,393 | $6,164 | $6,543 | $6,533 | $6,731 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,641 | 1,850 | 217 | 295 | 291 |
| TOTAL | $1,511 | $1,601 | $176 | $219 | $189 |
| Total Liabilities | $6,904 | $7,765 | $6,719 | $6,751 | $6,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26,000 | 25,440 | 24,301 | 23,542 | 16,773 |
| Common Shares | 26 | 25 | 24 | 20 | 15 |
| Retained earnings | -78,419 | -76,858 | -74,091 | -72,049 | -69,792 |
| Other shareholders' equity | 3,068 | 3,123 | 3,649 | 4,141 | 3,117 |
| TOTAL | $12,829 | $13,298 | $14,495 | $9,490 | $7,956 |
| Total Liabilities And Equity | $19,733 | $21,062 | $21,214 | $16,241 | $14,876 |